Items where authors include "Mankia, K."

Article

Di Matteo, A., Harnden, K., Sharrack, S. et al. (14 more authors) (2025) Ultrasound-detected inflammation and structural changes in the joints, tendons and entheses of patients with cancer who developed arthritis or arthralgia after exposure to immune checkpoint inhibitors. RMD Open, 11 (4). e005879. ISSN 2056-5933

David, P., Macleod, T., Altaie, A. orcid.org/0000-0002-9203-1490 et al. (16 more authors) (2025) Augmentation of immunothrombosis as a key mechanism underlying JAK inhibition associated hypercoagulability in rheumatoid arthritis. Annals of the Rheumatic Diseases. ISSN 0003-4967 (In Press)

Abacar, K., De Marco, G. orcid.org/0000-0003-2406-161X, Weddell, J. et al. (10 more authors) (2025) Late-Onset Spondylarthritis Presenting as Glucocorticoid-Resistant Polymyalgia Rheumatica: A hitherto underappreciated entity where TNF or IL-17 Blockade may have a Therapeutic Role. Arthritis & Rheumatology. ISSN 2326-5191 (In Press)

Harnden, K., Sidhu, N., Rowbotham, E. et al. (8 more authors) (2025) Whole-body MRI in patients with arthralgia or inflammatory arthritis after exposure to immune checkpoint inhibitors: a single-centre prospective imaging study. The Lancet Rheumatology. ISSN 2665-9913

Siddle, H.J., Wilson, M., Nam, J.L. et al. (5 more authors) (2024) A multivariable prediction model to identify anti-CCP positive people in those with non-specific musculoskeletal symptoms in primary care. Rheumatology. keae653. ISSN 1462-0324

Deane, K.D., Holers, V.M., Emery, P. orcid.org/0000-0002-7429-8482 et al. (9 more authors) (2024) Therapeutic interception in individuals at risk of rheumatoid arthritis to prevent clinically impactful disease. Annals of the Rheumatic Diseases. ISSN 0003-4967

Anioke, I. orcid.org/0000-0001-7600-4823, Duquenne, L., Parmar, R. et al. (4 more authors) (2024) Lymphocyte subset phenotyping for the prediction of progression to inflammatory arthritis in anti-citrullinated-peptide antibody-positive at-risk individuals. Rheumatology, 63 (6). pp. 1720-1732. ISSN 1462-0324

Gul, H. orcid.org/0000-0003-2546-8614, Di Matteo, A. orcid.org/0000-0003-0867-7051, Anioke, I. orcid.org/0000-0001-7600-4823 et al. (4 more authors) (2024) Predicting Flare in Patients With Rheumatoid Arthritis in Biologic Induced Remission, on Tapering, and on Stable Therapy. ACR Open Rheumatology, 6 (5). pp. 294-303. ISSN 2578-5745

Di Matteo, A. orcid.org/0000-0003-0867-7051, Mankia, K. orcid.org/0000-0002-7945-6582, Garcia-Montoya, L. et al. (5 more authors) (2024) Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody test. RMD Open, 10 (2). e003927. ISSN 2056-5933

Chapman, L.S. orcid.org/0000-0002-4207-2809, Siddle, H.J., Serban, S. orcid.org/0000-0001-7911-688X et al. (5 more authors) (2024) ‘What is my risk really?’: a qualitative exploration of preventive interventions among individuals at risk of rheumatoid arthritis. Rheumatology Advances in Practice, 8 (2). rkae023. ISSN 2514-1775

David, P. orcid.org/0000-0003-0075-5895, Di Matteo, A., Hen, O. et al. (9 more authors) (2024) Poly-Refractory Rheumatoid Arthritis: An Uncommon Subset of Difficult to Treat Disease With Distinct Inflammatory and Noninflammatory Phenotypes. Arthritis & Rheumatology, 76 (4). pp. 510-521. ISSN 2326-5191

Hemgren, C., Martinsson, K., Rooney, C. et al. (4 more authors) (2024) Elevated Serum Levels of Zonulin Family Peptides in Anticitrullinated Protein Antibody–Positive At-Risk Individuals Without Arthritis. The Journal of Rheumatology, 51 (2). pp. 134-138. ISSN 0315-162X

Garcia-Montoya, L., Kang, J., Duquenne, L. et al. (6 more authors) (2024) Factors associated with resolution of ultrasound subclinical synovitis in anti-CCP-positive individuals with musculoskeletal symptoms: a UK prospective cohort study. The Lancet Rheumatology, 6 (2). e72-e80. ISSN 2665-9913

Duquenne, L. orcid.org/0000-0001-7631-0986, Hensor, E.M. orcid.org/0000-0002-5245-4755, Wilson, M. et al. (11 more authors) (2023) Predicting Inflammatory Arthritis in At-Risk Persons: Development of Scores for Risk Stratification. Annals of Internal Medicine, 176 (8). pp. 1027-1036. ISSN 0003-4819

Chapman, L.S., Vinall-Collier, K. orcid.org/0000-0001-6362-9824, Siddle, H.J. et al. (1 more author) (2023) Correction: ‘It surprised me a lot that there is a link’: a qualitative study of the acceptability of periodontal treatment for individuals at risk of rheumatoid arthritis. RMD Open, 9 (2). e003099corr1. ISSN 2056-5933

Book Section

Yu, X., Mankia, K., Do, T. orcid.org/0000-0002-5668-2181 et al. (1 more author) (2025) Oral Microbiome Dysbiosis and Citrullination in Rheumatoid Arthritis. In: Dame-Teixeira, N., Deng, D. and Do, T., (eds.) Oral Microbiome: Symbiosis, Dysbiosis and Microbiome Interventions for Maintaining Oral and Systemic Health. Springer Nature , pp. 185-199. ISBN 978-3-031-79146-8

Conference or Workshop Item

Sharrack, S., Yu, X., Jayaraman, A. et al. (17 more authors) (2025) POS0067 Elevated serum peptidylarginine deiminase 4 (PAD4) levels in anti-CCP antibody positive at-risk individuals with arthralgia who progress to rheumatoid arthritis. In: EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain.

Yu, X., Hester, S., Harnden, K. et al. (10 more authors) (2023) POS0442 Endocitrullination Of RA Autoantigens Is More Abundant Than C-Terminal Citrullination In The Gingival Crevicular Fluid Of Anti-CCP Positive At-Risk Individuals With Periodontal Disease But No Synovitis. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.

Proceedings Paper

Siddle, H.J. orcid.org/0000-0002-6015-332X, Wilson, M., Nam, J.L. et al. (5 more authors) (2024) OA03 Developing a multivariable prediction model to identify anti-CCP positive individuals among those with non-specific musculoskeletal symptoms in primary care. In: Rheumatology. British Society for Rheumatology Annual Conference 2024, 24-26 Apr 2024, Liverpool, UK. Oxford University Press , i2-i2.